A Clinical Study of Recombinant Human Coagulation Factor VIII for Injection in Patients With Severe Hemophilia A
Condition(s):Hemophilia ALast Updated:March 7, 2024Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Hemophilia ALast Updated:March 7, 2024Not yet recruiting
Condition(s):Hemophilia ALast Updated:April 6, 2023Recruiting
Condition(s):Hemophilia A; Factor VIIILast Updated:February 16, 2024Recruiting
Condition(s):Hemophilia ALast Updated:January 25, 2024Recruiting
Condition(s):Factor VIII Deficiency, CongenitalLast Updated:March 15, 2024Recruiting
Condition(s):Hemophilia ALast Updated:July 12, 2022Not yet recruiting
Condition(s):Hemophilia ALast Updated:December 23, 2022Recruiting
Condition(s):Hemophilia ALast Updated:September 5, 2023Recruiting
Condition(s):Hemophilia ALast Updated:March 21, 2024Recruiting
Condition(s):Hemophilia A; Prophylaxis of BleedingLast Updated:March 8, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.